Clinical Trials
All Clinical Trials - Page 33 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT03790865Phase 2/Phase 3Terminated
Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome
Ghrp-6
- NCT03856632Phase 4Active Not Recruiting
Liraglutide Effect in Atrial Fibrillation
Liraglutide
- NCT03881995Phase 4Terminated
Effects of Insulin Glargine and Lixisenatide on the Brain
Lixisenatide
- NCT03841630Phase 1Completed
A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants
Retatrutide
- NCT03767543Phase 3Completed
Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)
Lixisenatide
- NCT03792555Phase 2Completed
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)
Octreotide
- NCT03888157N/ACompleted
A Research Study Looking at How Victoza® Works in People With Type 2 Diabetes in Iran, Followed in Local Clinical Routine
Liraglutide
- NCT03743025Phase 4Terminated
Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
Dulaglutide
- NCT03955575Phase 4Completed
Treatment of Bile Acid Malabsorption With Liraglutide
Liraglutide
- NCT03856047Phase 2Completed
Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.
Cagrilintide
- NCT03993366N/ACompleted
Pramlintide and Fiasp Closed-Loop With a Simple Meal Announcement
Pramlintide
- NCT03770338N/AActive Not Recruiting
Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery
Teriparatide
- NCT03846180N/ACompleted
Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage
Octreotide
- NCT03883412Phase 4Recruiting
Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)
Liraglutide
- NCT03642600Phase 4Completed
The Gut Microbiome in Women With Polycystic Ovary Syndrome
Liraglutide
- NCT03798080Phase 3Completed
Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin
Lixisenatide
- NCT03842202Phase 1Completed
A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity
Semaglutide
- NCT03798054Phase 3Completed
Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)
Lixisenatide
- NCT03746041Phase 1Completed
A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes
Abaloparatide
- NCT03835013N/ACompleted
Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
Exenatide
- NCT03800875Phase 2Completed
Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting
Pramlintide
- NCT03520569EARLY_Phase 1Completed
Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults
Octreotide
- NCT06725693N/ARecruiting
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
Exenatide
- NCT04194125Phase 2Unknown
Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer
Octreotide
- NCT03668470Phase 2Completed
Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes
Dulaglutide
- NCT02889393Phase 2Completed
Teduglutide for Enterocutaneous Fistula (ECF)
Teduglutide
- NCT03826160N/ACompleted
Growth Hormone Dynamics and Cardiac Steatosis in HIV
Tesamorelin
- NCT03741517N/AUnknown
Biomarker Study of Pancreatic Neuroendocrine Tumours
Octreotide
- NCT03541850Phase 2Active Not Recruiting
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery
Gonadorelin
- NCT03823339N/ACompleted
A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab Emirates
Liraglutide
- NCT04535960Phase 2Unknown
Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial
Liraglutide
- NCT03847207Phase 1Completed
A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310
Desmopressin
- NCT03811574Phase 3Completed
STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity
Semaglutide
- NCT03885297N/ACompleted
3mg Liraglutide for Overweight or Obesity
Liraglutide
- NCT03789578Phase 1Completed
A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together
Semaglutide
- NCT03375788Phase 2Completed
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
Tesamorelin
- NCT03442972Phase 2/Phase 3Completed
Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids
Teduglutide
- NCT03737240Phase 3Completed
IDegLira HIGH Trial
Liraglutide
- NCT03087032Phase 4Recruiting
Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
Liraglutide
- NCT04046822Phase 4Unknown
Effect of Liraglutide on Microbiome in Obesity
Liraglutide
- NCT03795701N/ACompleted
To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity
Liraglutide
- NCT03799198Phase 4Completed
Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity
Liraglutide
- NCT04371991N/ACompleted
Kisspeptin Levels in Early Pregnancy
Kisspeptin
- NCT03916640Phase 1Completed
A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus
Pramlintide
- NCT03659682Phase 2Unknown
GLP1R in Parkinson's Disease
Semaglutide
- NCT03380806Phase 2Unknown
Prostate Boost Irradiation With Stereotactic Body RT (SBRT)
Gonadorelin
- NCT03590626N/ACompleted
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Dulaglutide
- NCT03812939N/AUnknown
Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs
Octreotide
- NCT04916665N/ACompleted
Bridging Intestinal Failure With Teduglutide - a Case Report
Teduglutide
- NCT03959865N/AUnknown
GLP-1 REceptor Agonists and Real World EvIdeNce
Liraglutide